WILLIAM R RINGO
CIK 1238325 · Chief Executive Officer · last filed 2025-06-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$7.43M
Companies
12
Total Filings
152
Lifetime Open-Market Net
-$4.32M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ASMB | Director | 17,465 | $22.96 | $401.0K | -$510.4K | 23 | 2025-06-09 |
| SNSE | Director | 23,399 | $13.00 | $304.2K | $0 | 4 | 2025-05-23 |
| FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Chief Executive Officer | 0 | $38.00 | $0 | -$1.78M | 14 | 2021-04-19 |
| DERM | Director | 6,000 | $6.34 | $38.0K | -$165.7K | 17 | 2019-06-14 |
| FIVE PRIME THERAPEUTICS, INC. (XLRN) Delisted | Director | 10,000 | $178.75 | $1.79M | -$374.3K | 16 | 2019-06-12 |
| SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Director | 31,800 | $0.18 | $5.6K | -$1.10M | 15 | 2017-09-22 |
| Mirati Therapeutics, Inc. (MRTX) Delisted | Director | — | $58.70 | — | $0 | 4 | 2016-05-19 |
| ASSEMBLY BIOSCIENCES, INC. (VTUS) Delisted | Director | 20,465 | — | — | $0 | 1 | 2014-07-14 |
| ONYX PHARMACEUTICALS INC (ONXX) Delisted | Director | 9,837 | — | — | -$400.3K | 7 | 2013-04-01 |
| PFE | Senior Vice President | 255,139 | $26.21 | $6.69M | $0 | 37 | 2010-04-01 |
| ALLOS THERAPEUTICS INC (ALTH) Delisted | Director | 3,000 | — | — | $0 | 2 | 2007-06-21 |
| INSPIRE PHARMACEUTICALS INC (ISPH) Delisted | Director | — | — | — | $0 | 1 | 2007-06-12 |
Recent Filings · Page 2 of 16
152 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-11-13 | FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Mixed | — | -$1.59M | EDGAR |
| 2020-06-15 | ASMB | Mixed | −2,000 | $0 | EDGAR |
| 2020-05-20 | FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-04-20 | FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-03-20 | FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-02-24 | — | Disp (D) | −6,000 | -$112.5K | |
| 2020-02-20 | FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-01-21 | FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-01-21 | FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-12-20 | FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.